{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:14:32Z","timestamp":1761743672218},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T00:00:00Z","timestamp":1343952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00784-012-0800-7","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T09:28:17Z","timestamp":1343899697000},"page":"1259-1266","source":"Crossref","is-referenced-by-count":21,"title":["Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid"],"prefix":"10.1007","volume":"17","author":[{"given":"Marco","family":"Mozzati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germana","family":"Martinasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Maggiora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Scoletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Zambelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Carossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Oraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Muzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Angela","family":"Canuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,3]]},"reference":[{"key":"800_CR1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jnci\/djq516","volume":"103","author":"M Pazianas","year":"2011","unstructured":"Pazianas M (2011) Osteonecrosis of the jaw and the role of macrophages. J Natl Cancer Inst 103:232\u2013240","journal-title":"J Natl Cancer Inst"},{"key":"800_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.joms.2009.01.012","volume":"67","author":"B Mehrotra","year":"2009","unstructured":"Mehrotra B (2009) Bisphosphonates\u2014role in cancer therapies. J Oral Maxillofac Surg 67:19\u201326","journal-title":"J Oral Maxillofac Surg"},{"key":"800_CR3","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/jm7015733","volume":"51","author":"JE Dunford","year":"2008","unstructured":"Dunford JE, Kwaasi AA, Rogers MJ et al (2008) Structure\u2013activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. J Med Chem 51:2187\u20132195","journal-title":"J Med Chem"},{"key":"800_CR4","first-page":"1725","volume-title":"Osteoporosis","author":"R Marcus","year":"2008","unstructured":"Marcus R, Feldman D, Nelson D et al (2008) Bisphosphonates: pharmacology and use in the treatment of osteoporosis. In: Marcus R, Feldman D, Nelson D, Rosen C (eds) Osteoporosis, 3rd edn. Elsevier, Burlington, pp 1725\u20131742","edition":"3"},{"key":"800_CR5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.joms.2009.11.015","volume":"68","author":"M Frei","year":"2010","unstructured":"Frei M, Bornstein MM, Schaller B et al (2010) Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case. J Oral Maxillofac Surg 68:863\u2013867","journal-title":"J Oral Maxillofac Surg"},{"key":"800_CR6","first-page":"505","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"NS Treister","year":"2009","unstructured":"Treister NS, Sook-Bin W (2009) Bisphosphonate-associated osteonecrosis of the jaws. In: Rosen CJ, Compston JE, Lian JB (eds) Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th edn. Wiley, Hoboken, pp 505\u2013509","edition":"7"},{"key":"800_CR7","first-page":"2893","volume":"9","author":"D Santini","year":"2003","unstructured":"Santini D, Vincenzi B, Dicuonzo G et al (2003) Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients, and by \u201cin vitro\u201d research. Clin Cancer Res 9:2893\u20132897","journal-title":"Clin Cancer Res"},{"key":"800_CR8","first-page":"6538","volume":"62","author":"P Fournier","year":"2002","unstructured":"Fournier P, Boissier S, Filleur S et al (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62:6538\u20136544","journal-title":"Cancer Res"},{"key":"800_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","volume":"35","author":"T Hansen","year":"2006","unstructured":"Hansen T, Kunkel M, Weber A et al (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155\u2013160","journal-title":"J Oral Pathol Med"},{"key":"800_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","volume":"63","author":"JW Hellstein","year":"2005","unstructured":"Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63:682\u2013689","journal-title":"J Oral Maxillofac Surg"},{"key":"800_CR11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","volume":"44","author":"IR Reid","year":"2009","unstructured":"Reid IR (2009) Osteonecrosis of the jaw: who gets it, and why? Bone 44:4\u201310","journal-title":"Bone"},{"key":"800_CR12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00784-011-0614-z","volume":"16","author":"JY Ohe","year":"2012","unstructured":"Ohe JY, Kwon YD, Lee HW (2012) Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. Clin Oral Investig 16:1153\u20131159","journal-title":"Clin Oral Investig"},{"key":"800_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00784-010-0477-8","volume":"16","author":"FP Koch","year":"2012","unstructured":"Koch FP, Merkel C, Ziebart T et al (2012) Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Clin Oral Investig 16:79\u201386","journal-title":"Clin Oral Investig"},{"key":"800_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","volume":"48","author":"M Mozzati","year":"2012","unstructured":"Mozzati M, Gallesio G, Arata V et al (2012) Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 48:469\u2013474","journal-title":"Oral Oncol"},{"key":"800_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/pho.2010.2921","volume":"29","author":"M Mozzati","year":"2011","unstructured":"Mozzati M, Martinasso G, Cocero N et al (2011) Influence of superpulsed laser therapy on healing processes following tooth extraction. Photomed Laser Surg 29:565\u2013571","journal-title":"Photomed Laser Surg"},{"key":"800_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tripleo.2007.01.040","volume":"104","author":"SD Bianchi","year":"2007","unstructured":"Bianchi SD, Scoletta M, Cassione FB et al (2007) Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:249\u2013258","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"800_CR17","doi-asserted-by":"crossref","unstructured":"Pavlakis N, Schmidt R, Stockler M (2005) Bisphosphonates for breast cancer. Cochrane Database Syst Rev 3:CD003474","DOI":"10.1002\/14651858.CD003474.pub2"},{"key":"800_CR18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","volume":"19","author":"M Aapro","year":"2008","unstructured":"Aapro M, Abrahamsson PA, Body JJ et al (2008) Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 19:420\u2013432","journal-title":"Ann Oncol"},{"key":"800_CR19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00520-008-0484-3","volume":"16","author":"N Verde La","year":"2008","unstructured":"La Verde N, Bareggi C, Garassino M et al (2008) Osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates: how the knowledge of a phenomenon can change its evolution. Support Care Cancer 16:1311\u20131315","journal-title":"Support Care Cancer"},{"key":"800_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JOP.2.1.7","volume":"2","author":"S Ruggiero","year":"2006","unstructured":"Ruggiero S, Gralow J, Marx RE et al (2006) Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2:7\u201314","journal-title":"J Oncol Pract"},{"key":"800_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/annonc\/mdr039","volume":"23","author":"AM Vandone","year":"2011","unstructured":"Vandone AM, Donadio M, Mozzati M et al (2011) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol 23:193\u2013200","journal-title":"Ann Oncol"},{"key":"800_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, O\u2019Ryan FS, Gordon NP et al (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243\u2013253","journal-title":"J Oral Maxillofac Surg"},{"key":"800_CR23","first-page":"c246","volume":"340","author":"J Shannon","year":"2011","unstructured":"Shannon J, Shannon J, Modelevsky S et al (2011) Bisphosphonates and osteonecrosis of the jaw. J Am Geriatr Soc 340:c246. doi: 10.1111\/j.1532-5415.2011.03713.x","journal-title":"J Am Geriatr Soc"},{"key":"800_CR24","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1007\/PL00004164","volume":"9","author":"RG Russell","year":"1999","unstructured":"Russell RG, Croucher PI, Rogers MJ (1999) Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Oteoporos Int 9:S66\u2013S80","journal-title":"Oteoporos Int"},{"key":"800_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/annonc\/mdl298","volume":"18","author":"D Santini","year":"2007","unstructured":"Santini D, Vincenzi B, Caraglia M et al (2007) A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss. Ann Oncol 18:201\u2013202","journal-title":"Ann Oncol"},{"key":"800_CR26","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jbmr.410","volume":"26","author":"A Rufo","year":"2011","unstructured":"Rufo A, Del Fattore A, Capulli M et al (2011) Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26:1891\u20131903. doi: 10.1002\/jbmr.410","journal-title":"J Bone Miner Res"},{"key":"800_CR27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1601-0825.2010.01781.x","volume":"17","author":"E Jimi","year":"2010","unstructured":"Jimi E, Furuta H, Matsuo K et al (2010) The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma. Oral Dis 17:462\u2013468. doi: 10.1111\/j.1601-0825.2010.01781.x","journal-title":"Oral Dis"},{"key":"800_CR28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2005.02665.x","volume":"139","author":"RE Hewitt","year":"2005","unstructured":"Hewitt RE, Lissina A, Green AE et al (2005) The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood \u03b3\u03b4 T cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol 139:101\u2013111","journal-title":"Clin Exp Immunol"},{"key":"800_CR29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","volume":"144","author":"SB Woo","year":"2006","unstructured":"Woo SB, Hellstein JW, Kalmar JR (2006) Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753\u2013761","journal-title":"Ann Intern Med"},{"key":"800_CR30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jcp.22808","volume":"227","author":"D Kraus","year":"2012","unstructured":"Kraus D, Deschner J, J\u00e4ger A et al (2012) Human \u03b2-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol 227:994\u20131003. doi: 10.1002\/jcp.22808","journal-title":"J Cell Physiol"},{"key":"800_CR31","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/jcp.22550","volume":"226","author":"V Krishnan","year":"2011","unstructured":"Krishnan V, Shuman LA, Sosnoski DM et al (2011) Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures. J Cell Physiol 226:2150\u20132158","journal-title":"J Cell Physiol"},{"key":"800_CR32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","volume":"1218","author":"R Landesberg","year":"2011","unstructured":"Landesberg R, Woo V, Cremers S et al (2011) Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci 1218:62\u201379. doi: 10.1111\/j.1749-6632.2010.05835.x","journal-title":"Ann N Y Acad Sci"},{"key":"800_CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00784-009-0294-0","volume":"14","author":"J Rustemeyer","year":"2010","unstructured":"Rustemeyer J, Bremerich A (2010) Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature. Clin Oral Investig 14:59\u201364","journal-title":"Clin Oral Investig"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-012-0800-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-012-0800-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-012-0800-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T12:08:46Z","timestamp":1562069326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-012-0800-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,3]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s00784-012-0800-7","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,3]]}}}